209 related articles for article (PubMed ID: 15763342)
1. The newly established human hepatocyte cell line: application for the bioartificial liver.
Harimoto N; Taketomi A; Kitagawa D; Kuroda Y; Itoh S; Gion T; Tanaka S; Shirabe K; Shimada M; Maehara Y
J Hepatol; 2005 Apr; 42(4):557-64. PubMed ID: 15763342
[TBL] [Abstract][Full Text] [Related]
2. Polyurethane foam/spheroid culture system using human hepatoblastoma cell line (Hep G2) as a possible new hybrid artificial liver.
Yamashita Y; Shimada M; Tsujita E; Tanaka S; Ijima H; Nakazawa K; Sakiyama R; Fukuda J; Ueda T; Funatsu K; Sugimachi K
Cell Transplant; 2001; 10(8):717-22. PubMed ID: 11814114
[TBL] [Abstract][Full Text] [Related]
3. Insertion of a suicide gene into an immortalized human hepatocyte cell line.
Kobayashi N; Noguchi H; Totsugawa T; Watanabe T; Matsumura T; Fujiwara T; Miyazaki M; Fukaya K; Namba M; Tanaka N
Cell Transplant; 2001; 10(4-5):373-6. PubMed ID: 11549056
[TBL] [Abstract][Full Text] [Related]
4. [Experimental study of dually targeting gene therapy system for pituitary adenomas].
Ma CY; Lu YC; Shi JX; Ren CC; Zhu JD; Gu JR
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(4):262-6. PubMed ID: 15854489
[TBL] [Abstract][Full Text] [Related]
5. Coencapsulation of hepatocytes with bone marrow mesenchymal stem cells improves hepatocyte-specific functions.
Shi XL; Zhang Y; Gu JY; Ding YT
Transplantation; 2009 Nov; 88(10):1178-85. PubMed ID: 19935371
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of hepatocytes derived from early ES cells and treatment of surgically induced liver failure rats by transplantation.
Tabei I; Hashimoto H; Ishiwata I; Tachibana T; Akahori M; Ohi S; Kubo H; Satou K; Yamazaki Y; Yanaga K; Ishikawa H
Transplant Proc; 2005; 37(1):262-4. PubMed ID: 15808614
[TBL] [Abstract][Full Text] [Related]
7. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes.
Soto-Gutiérrez A; Kobayashi N; Rivas-Carrillo JD; Navarro-Alvarez N; Zhao D; Okitsu T; Noguchi H; Basma H; Tabata Y; Chen Y; Tanaka K; Narushima M; Miki A; Ueda T; Jun HS; Yoon JW; Lebkowski J; Tanaka N; Fox IJ
Nat Biotechnol; 2006 Nov; 24(11):1412-9. PubMed ID: 17086173
[TBL] [Abstract][Full Text] [Related]
8. [Anti-glioma activity of treatment by bone marrow stromal cells transfected with HSV-tk in the rat].
Li CH; Jiao BH
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):171-5. PubMed ID: 17649630
[TBL] [Abstract][Full Text] [Related]
9. Human fetal hepatocyte line, L-02, exhibits good liver function in vitro and in an acute liver failure model.
Hu X; Yang T; Li C; Zhang L; Li M; Huang W; Zhou P
Transplant Proc; 2013 Mar; 45(2):695-700. PubMed ID: 23498809
[TBL] [Abstract][Full Text] [Related]
10. Treatment of surgically induced acute liver failure by transplantation of HNF4-overexpressing embryonic stem cells.
Kuai XL; Cong XQ; Du ZW; Bian YH; Xiao SD
Chin J Dig Dis; 2006; 7(2):109-16. PubMed ID: 16643339
[TBL] [Abstract][Full Text] [Related]
11. Ammonia metabolism capacity of HepG2 cells with high expression of human glutamine synthetase.
Tang NH; Wang XQ; Li XJ; Chen YL
Hepatobiliary Pancreat Dis Int; 2008 Dec; 7(6):621-7. PubMed ID: 19073408
[TBL] [Abstract][Full Text] [Related]
12. Intrasplenic transplantation of encapsulated cells: a novel approach to cell therapy.
Aoki T; Umehara Y; Ferraresso C; Sugiyama N; Middleton Y; Avital I; Inderbitzin D; Demetriou AA; Rozga J
Cell Transplant; 2002; 11(6):553-61. PubMed ID: 12428745
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of human thioredoxin gene-modified hepatocytes for treatment of acute liver failure in rat model.
Li H; Jiang N; Zhang J; Wang GS; Yang Y; Chen GH
Chin Med J (Engl); 2009 Nov; 122(21):2631-5. PubMed ID: 19951583
[TBL] [Abstract][Full Text] [Related]
14. [Construction and identification of recombinant vectors carrying herpes simplex virus thymidine kinase genes expressed in vascular endothelial cells].
Liu XP; Li BJ; Zhang C
Ai Zheng; 2006 Feb; 25(2):179-84. PubMed ID: 16480582
[TBL] [Abstract][Full Text] [Related]
15. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
16. Treatment of liver failure in rats with end-stage cirrhosis by transplantation of immortalized hepatocytes.
Cai J; Ito M; Nagata H; Westerman KA; Lafleur D; Chowdhury JR; Leboulch P; Fox IJ
Hepatology; 2002 Aug; 36(2):386-94. PubMed ID: 12143047
[TBL] [Abstract][Full Text] [Related]
17. Systematic analysis of the effects of hepatocyte transplantation on rats with acute liver failure.
Kim WH; Lee JH; Han SU; Jin YM; Kwak YS; Wang HJ; Kim MW
Hepatogastroenterology; 2000; 47(32):371-4. PubMed ID: 10791192
[TBL] [Abstract][Full Text] [Related]
18. In vivo estimation of bioartificial liver with recombinant HepG2 cells using pigs with ischemic liver failure.
Enosawa S; Miyashita T; Fujita Y; Suzuki S; Amemiya H; Omasa T; Hiramatsu S; Suga K; Matsumura T
Cell Transplant; 2001; 10(4-5):429-33. PubMed ID: 11549067
[TBL] [Abstract][Full Text] [Related]
19. A bioartificial liver support system using primary hepatocytes: a preclinical study in a new porcine hepatectomy model.
Frühauf NR; Oldhafer KJ; Höltje M; Kaiser GM; Frühauf JH; Stavrou GA; Bader A; Broelsch CE
Surgery; 2004 Jul; 136(1):47-56. PubMed ID: 15232539
[TBL] [Abstract][Full Text] [Related]
20. [Herpes simplex virus type 1 thymidine kinase/ganciclovir (HSV(1)-TK/GCV) system as an effective "in vivo death switch" of live tumor vaccines].
Kang Y; Xu CJ; Liu XS; Wu CQ; Zhong CP; Gu JR
Ai Zheng; 2005 Aug; 24(8):909-14. PubMed ID: 16086864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
